(Q46520802)

22 December 2017

title

Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

1

1 reference

22 December 2017

author name string

Ko Kotani

series ordinal

2

1 reference

22 December 2017

Odile D Peroni

series ordinal

3

1 reference

22 December 2017

Barbara B Kahn

series ordinal

4

1 reference

22 December 2017

publication date

31 May 2005

1 reference

22 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

22 December 2017

volume

289

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

E551-61

1 reference

22 December 2017

Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Regulation of fasted blood glucose by resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

GLUT4 overexpression or deficiency in adipocytes of transgenic mice alters the composition of GLUT4 vesicles and the subcellular localization of GLUT4 and insulin-responsive aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Insulin receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Role of resistin in diet-induced hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Adiponectin: systemic contributor to insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00116.2005

10.1152/AJPENDO.00116.2005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15928024

1 reference

22 December 2017